Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1130620100060040159
Journal of Clinical Neurology
2010 Volume.6 No. 4 p.159 ~ p.166
Seniors with Parkinson¡¯s Disease: Initial Medical Treatment
Ahlskog J. Eric

Abstract
Parkinson¡¯s disease most often presents after age 60, and patients in this age group are best managed with levodopa therapy as the primary treatment modality. Unlike young-onset parkinsonism (onset £¼age 40), this older age group is much less prone to subsequent development of levodopa responsive instability (dyskinesias, fluctuations). When these problems do occur in seniors, they usually can be managed by medication adjustments. The treatment goal is to keep patients active and engaged; levodopa dosage should be guided by the patients¡¯ responses and not arbitrarily limited to low doses, which may compromise patients¡¯ lives.
KEYWORD
Parkinson¡¯s disease, levodopa, dopamine agonists, dyskinesias
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø